Skip to content

Investment Losses Recovery Law Firm

Shareholder Rights Law, Prosecuting Investment Fraud for Over 40 Years

  • Search
  • Investigations & Lawsuits
    • Current Investigations
    • Closed Investigations & Closed Lawsuits
  • Securities Fraud
    • Breach of Contract
    • Breach of Fiduciary Duty
    • Broker Misconduct
    • Churning
    • Derivative Lawsuit
    • ERISA Violations
    • Failure to Supervise
    • FINRA Arbitration
    • Mergers and Acquisitions
    • Misrepresentations and Omissions
    • Negligence
    • Overconcentration (Over Concentration)
    • Unsuitability (the Suitability Rule)
  • Securities
    • Stocks (Capital Stock)
    • Bonds (Debt Securities)
    • Funds (Mutual Funds)
    • REIT (Real Estate Investment Trust)
    • High Yield Bonds (Junk Bonds)
    • Reverse Convertibles
    • Variable Annuities
    • Preferred Stock (Preferred Securities)
    • Hedge Funds
    • Principal Protected Notes
    • Private Placement
    • Tenants In Common (TICs)
    • Options (Stock Options)
    • Futures and Commodities
    • Municipal Bonds
  • Free Consultation
  • Plaintiff Certification Form
  • Contact Us
    • About Us
    • Free Consultation and Case Review
Investment Losses Recovery Law Firm

WageWorks, Inc. [NYSE: WAGE]

WageWorks, Inc.

[NYSE: WAGE]; based in San Mateo, California; incorporated in Delaware

Deadline: 05/08/2018

Case #: 18-cv-1523

Court: USDC, Northern District of California

Lead or Derivative; Class Period is 5/6/2016 to 3/1/2018

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Ubiquiti Networks, Inc. [NASDAQ: UBNT]

Ubiquiti Networks, Inc.

[NASDAQ: UBNT]; based in New York, New York; incorporated in Delaware

Deadline: 04/23/2018

Case #: 18-cv-1620

Court: USDC, Southern District of New York

Lead or Derivative; Class Period is 5/9/2013 to 2/20/2018

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Obalon Therapeutics, Inc. [NASDAQ: OBLN]

Obalon Therapeutics, Inc.

[NASDAQ: OBLN]; based in Carlsbad, California; incorporated in Delaware

Deadline: 04/16/2018

Case #: 18-cv-352

Court: USDC, Southern District of California

Lead or Derivative; Class Period is 10/5/2016 to 1/23/2018

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Aflac Incorporated [NYSE: AFL]

Aflac Incorporated

[NYSE: AFL]; based in Columbus, Georgia; incorporated in Georgia

Deadline: 04/16/2018

Case #: 18-cv-31

Court: USDC, Middle District of Georgia

Lead or Derivative; Class Period is 2/27/2013 to 1/11/2018

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Ulta Beauty, Inc. [NASDAQ: ULTA]

Ulta Beauty, Inc.

[NASDAQ: ULTA]; based in Bolingbrook, Illinois; incorporated in Delaware

Deadline: 05/01/2018

Case #: 18-cv-1577

Court: USDC, Southern District of Illinois

Lead or Derivative; Class Period is 3/40/2016 to 2/23/2018

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Kraton Corporation [NYSE; KRA]

Kraton Corporation

[NYSE; KRA]; based in Houston, Texas; incorporated in Delaware

Deadline: 04/27/2018

Case #: 18-cv-591

Court: USDC, Southern District of Texas

Lead or Derivative; Class Period is 10/25/2017 to 2/21/2018

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Advance Auto Parts, Inc. [NYSE: AAP]

Advance Auto Parts, Inc.

[NYSE: AAP]; based in Roanoke, Virginia; incorporated in Delaware

Lead Plaintiff Deadline: 04/09/2018

Case #: 18-cv-212

Court: USDC District of Delaware

Notes: Lead or Derivative Plaintiffs; Class Period is 11/14/2016 to 8/15/2017

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Bellicum Pharmaceuticals, Inc. [NASDAQ: BLCM]

Bellicum Pharmaceuticals, Inc.

[NASDAQ: BLCM]; based in Houston, Texas; incorporated in Delaware

Lead Plaintiff Deadline: 04/09/2018

Case #: 18-cv-338

Court: USDC, Southern District of Texas

Notes: Lead or Derivative Plaintiffs; Class Period is 5/8/2017 to 1/40/2018

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Quantum Corporation [NYSE: QTM]

Quantum Corporation

[NYSE: QTM] based in San Jose, California; incorporated in Delaware

Lead Plaintiff Deadline: 04/16/2018

Case #: 18-cv-923

Court: USDC, Northern District of California

Notes: Lead or Derivative Plaintiffs; Class Period is 7/27/2016 to 2/7/2018

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Ohr Pharmaceutical, Inc. [NASDAQ: OHRP]

Ohr Pharmaceutical, Inc.
[NASDAQ: OHRP]; based in New York, New York; incorporated in Delaware

Lead Plaintiff Deadline: 04/16/2018

Case #: 18-cv-1284

Court: USDC, Southern District of New York

Notes: Lead or Derivative Plaintiffs; Class Period is 6/24/2014 to 1/4/2018

This entry was posted in Newly Filed Cases on April 10, 2018 by Gilman Law.

Post navigation

← Older posts
Newer posts →

Recent Posts

  • Live Nation Entertainment, Inc. [NYSE: LYV]
  • Colony NorthStar, Inc. [NYSE: CLNS]
  • IZEA, Inc. [NASDAQ: IZEA]
  • Synacor, Inc. [NASDAQ: SYNC]
  • Longfin Corp. [NASDAQ: LFIN]

Awards & Recognition

Gilman Law LLP and its attorneys have been recognized by the leading legal publications and are listed in:

Avvo Rating
Life Member, Multi-Million Dollar Advocates Forum
Life Member, Million Dollar Advocates Forum
Super Lawyers
Lexis Nexis
LawDragon
Association of Trial Lawyers of America
Massachusetts Association of Woman’s Lawyers
American Association of Justice: Leaders Forum
American Bar Association and Member of the ABA Antitrust and Litigation Sections and Forum on Franchising and Litigation Section
Public Investors Arbitration Bar Association

Disclaimer: Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us. Prior results do not guarantee or predict a similar outcome with respect to any future matter. The information contained on this Web site is not medical advice or legal advice, and is not intended to be medical advice or legal advice. Nor is it a substitute for seeking appropriate medical, legal, or other professional advice. Please discuss any health or other concerns with your doctor or other healthcare professional. No recommendation or endorsement of Gilman Law LLP is implied by reference to any newspaper or television or radio station. Your use of this web site, or sending of email to Gilman Law LLP, does not create an attorney- client relationship between you and Gilman Law LLP.

Privacy Policy: Gilman Law LLP maintains the strict and confidential privacy of your message. We do not transfer your personal information, including your email address, to any third party. Information entered in the form will be used solely for informational purposes to assist in your case investigation.

Proudly powered by WordPress